IMA · NASDAQ
ImageneBio (IMA) Stock Price & Fundamentals
ImageneBio (IMA) closed at $929.50 on Oct 9, 2026, up 1.42% from the previous close of $916.47.
Share price, past year
1Y +23.28%Monthly closing prices
| Date | Close |
|---|---|
| Oct 9, 2026 | $929.50 |
| Sep 30, 2026 | $897.94 |
| Aug 31, 2026 | $899.73 |
| Jul 31, 2026 | $906.40 |
| Jun 30, 2026 | $894.60 |
| May 29, 2026 | $845.77 |
| Apr 30, 2026 | $844.15 |
| Mar 31, 2026 | $799.98 |
| Feb 27, 2026 | $783.49 |
| Jan 30, 2026 | $806.84 |
| Dec 31, 2025 | $793.94 |
| Nov 28, 2025 | $756.91 |
| Oct 31, 2025 | $767.12 |
Key statistics
- Market cap
- $44.86B
- P/E (TTM)
- —
- EPS (TTM)
- −$2.96
- Revenue (TTM)
- —
- Net income (TTM)
- −$52.48M
- Shares outstanding
- 48.3M
- Dividend yield
- —
- 52-week range
- $734.52 – $929.50
ImageneBio's market cap is $44.86B, based on a share price of $929.50 and 48.3M shares outstanding as of Jun 30, 2025.
Financials
ImageneBio reported revenue of $800.00K for fiscal 2025, down 77.14% from fiscal 2024.
ImageneBio reported a net loss of $45.35M in fiscal 2025.
Annual revenue
| Fiscal year | Revenue | Growth | Net income | Net margin | EPS (diluted) | Free cash flow |
|---|---|---|---|---|---|---|
| FY2025ended Dec 31, 2025 | $800.00K | −77.1% | −$45.35M | −5,668.6% | −$9.64 | — |
| FY2024ended Dec 31, 2024 | $3.50M | −61.8% | −$36.57M | −1,044.8% | −$22.10 | — |
| FY2023ended Dec 31, 2023 | $9.16M | −41.4% | −$68.17M | −744.2% | −$1.63 | −$80.16M |
| FY2022ended Dec 31, 2022 | $15.62M | −49.6% | −$68.77M | −440.3% | −$1.90 | −$75.54M |
| FY2021ended Dec 31, 2021 | $30.99M | +237.0% | −$34.12M | −110.1% | −$1.22 | −$62.01M |
| FY2020ended Dec 31, 2020 | $9.19M | — | −$44.26M | −481.4% | −$16.00 | −$38.59M |
| Quarter | Revenue | Net income | EPS (diluted) |
|---|---|---|---|
| Q3 FY2025ended Sep 30, 2025 | $0.00 | −$24.78M | −$2.91 |
| Q1 FY2025ended Mar 31, 2025 | $800.00K | −$6.08M | −$3.80 |
| Q3 FY2024ended Sep 30, 2024 | $3.50M | −$3.18M | −$2.58 |
| Q4 FY2023ended Dec 31, 2023 | $658.00K | — | — |
| Q3 FY2023ended Sep 30, 2023 | $1.19M | — | — |
| Q2 FY2023ended Jun 30, 2023 | $2.00M | — | — |
| Q1 FY2023ended Mar 31, 2023 | $5.31M | — | — |
| Q4 FY2022ended Dec 31, 2022 | $5.45M | — | — |
Company profile
- Name
- ImageneBio, Inc.
- Ticker
- IMA
- Exchange
- NASDAQ
- Industry (SEC SIC)
- Biological Products, (No Diagnostic Substances)
- Headquarters
- 12526 High Bluff Drive, San Diego, CA 92130
- Incorporated in
- DE
- Fiscal year ends
- December
- SEC CIK
- 0001835579
Recent SEC filings
- Aug 5, 2026
- Aug 5, 2026
- Jul 23, 2026
- Jun 26, 2026
- Jun 17, 2026
- May 7, 2026
- May 7, 2026
- Apr 13, 2026
Frequently asked questions
What is ImageneBio's stock price?
ImageneBio (IMA) closed at $929.50 on Oct 9, 2026, up 1.42% from the previous close of $916.47.
What is ImageneBio's market cap?
ImageneBio's market cap is $44.86B, based on a share price of $929.50 and 48.3M shares outstanding as of Jun 30, 2025.
How much revenue does ImageneBio make?
ImageneBio reported revenue of $800.00K for fiscal 2025, down 77.14% from fiscal 2024.
Does ImageneBio pay a dividend?
ImageneBio's recent filings report no dividends declared over the last four quarters.
Sources and methodology
Fundamentals come from ImageneBio, Inc.'s filings with the SEC (EDGAR XBRL company facts). Fourth-quarter figures that companies don't report separately are calculated as the fiscal year minus the first three quarters. Trailing twelve-month (TTM) figures sum the latest four quarters. Prices are generated sample data for development. Last updated Oct 9, 2026. Data sources and disclosures